Status:

COMPLETED

Prediction of Recurrent Pregnancy Loss by a New Thrombophilia Based Genetic Risk Score

Lead Sponsor:

Ferrer inCode, S.L.

Collaborating Sponsors:

Clinica Universidad de Navarra, Universidad de Navarra

Instituto de Salud Carlos III

Conditions:

Miscarriage, Recurrent

Eligibility:

FEMALE

18-37 years

Brief Summary

Recurrent pregnancy loss (RPL) is a clinical problem affecting 1-5% of couples of reproductive age. The contribution of thrombophilia to RPL is disputed. This controversy is partly due to low sensitiv...

Detailed Description

Recurrent pregnancy loss can affect up to 5% of women in child-bearing age and is considered one of the most common causes of female sterility. In recent years, the association between thrombophilia a...

Eligibility Criteria

Inclusion

  • CONTROLS
  • Women \>18 and \< 38 years old at the time of the first pregnancy.
  • Women with successful implantation and at least one full-term pregnancy
  • No chronic pathology

Exclusion

  • Personal or family history of thrombosis
  • Personal history of obstetric complications Miscarriage or foetal death Pre-eclampsia or eclampsia Intrauterine growth restriction Placental abruption
  • Concomitant anticoagulant treatment and/or antiplatelet treatments during pregnancy
  • CASES
  • Inclusion Criteria:
  • Repeated clinical miscarriages and/or foetal death (≥ 2 consecutive or ≥ 3 non- consecutive) before the 20th weeks of pregnancy, from spontaneous or assisted pregnancies.
  • Recurrent miscarriage with the same gametic origin.
  • Idiopathic origin:
  • Women \< 38 years old Non-severe seminal factor (sperm concentration \> 2 mill/ml) Normal karyotypes in both spouses (or in the male and the donor in the case of ovocyte donation) Antiphospholipid syndrome negative Normal or corrected thyroid function BMI \< 30

Key Trial Info

Start Date :

February 1 2015

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 1 2017

Estimated Enrollment :

364 Patients enrolled

Trial Details

Trial ID

NCT03336463

Start Date

February 1 2015

End Date

January 1 2017

Last Update

November 8 2017

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

Clinica Universitaria de Navarra

Pamplona, Navarre, Spain, 31008

2

Gendiag.exe, S.L.

Esplugues de Llobregat, Select State, Spain, 08950

3

Institut d'Investigació Sant Pau

Barcelona, Spain, 08025

4

Instituto Salud Carlos III

Madrid, Spain, 28029